Xanor & Xanor Sr Tablet
PDF Leaflet Revision Date: 14 January 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term relief of anxiety symptoms and treatment of anxiety disorders.
Dosage (summary)
Starting dose: 0.25-0.5 mg three times daily; max: 4 mg daily.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding due to potential risks.
Key Drug Interactions
- Opioids
- CYP3A4 inhibitors
- Alcohol
Contraindications
- Hypersensitivity to benzodiazepines
- Severe respiratory insufficiency
- Myasthenia gravis
Common side effects
- Sedation
- Dizziness
- Confusional state
- Dry mouth
Counselling Points
- Avoid alcohol
- Do not drive until effects are known
- Gradually reduce dosage when discontinuing
Serious warnings
- Risk of dependence
- Withdrawal symptoms
- Caution in elderly
Important Disclaimer
The Xanor & Xanor Sr Tablet professional information leaflet below is the property of Upjohn South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
